Kaiser Permanente: Atypical Femur Fractures Rise With Longer Bisphosphonate Use
August 21, 2020
August 21, 2020
PASADENA, California, Aug. 21 -- Kaiser Permanente issued the following news release:
In a study published in the New England Journal of Medicine, Kaiser Permanente Southern California research scientists report that while atypical femur fracture risk is rare, it does increase with longer use of bisphosphonate to treat osteoporosis, especially after 5 years. Asian women had approximately 5 times the risk of these fractures with prolonged bisphosphonate use compared to white women.< . . .
In a study published in the New England Journal of Medicine, Kaiser Permanente Southern California research scientists report that while atypical femur fracture risk is rare, it does increase with longer use of bisphosphonate to treat osteoporosis, especially after 5 years. Asian women had approximately 5 times the risk of these fractures with prolonged bisphosphonate use compared to white women.< . . .